- Coronary stents
- PTCA balloon catheters
- Coronary guidewires
The Coronary Heart Disease Medical Devices Market size was valued at USD 1.46 billion in 2021, growing at a CAGR of 6.5% from 2022-28. Coronary heart diseases allude to a narrowing of the coronary veins, the veins that supply oxygen and blood screening to the heart. It is otherwise called a coronary supply route malady. It is a noteworthy reason for ailment and demise. Coronary heart disease (CHD) regularly happens when cholesterol collects on the course dividers, making plaques. The arteries narrow, lessening the bloodstream to the heart. Now and then, coagulation can deter the stream of blood to the heart muscle. CHD generally causes angina pectoris (chest torment), shortness of breath, myocardial dead tissue, or heart attack. The coronary heart disease medical devices market is exceptionally composed and focused because of the nearness of some large, medium, and small players. Multinational merchants possess a substantial piece of the worldwide market and constantly contend with each other to pick up lion's share of partakes in the market. The focused condition in the market is relied upon to strengthen amid the conjecture time frame inferable from progress in innovation, item expansions, and expanded M&A. This report studies global coronary heart disease medical devices market dynamics elaborately to identify the current trends & drivers, future opportunities, and possible challenges to the key stakeholders operating in the market. In addition, the report includes human demographics; regulatory scenario, and competition analysis with a vividly illustrated competition dashboard to assess the market competition.
Fastest Growing Market
coronary heart disease medical devices market is driven by growing aging population who are very susceptible to the coronary heart diseases and technological develepments in coronary heart disease medical devices that minimizing the chances of infection and improved efficiency of devices. In addition, rising number of cases of heart failure and shortage of donors for late stage heart failure patients expected to boost the global coronary heart disease medical devices market during the forecast period. Furthermore, coronary heart disease medical devices are one of the more reliable and efficient options for the heart failure management. However, factors such as availability of alternative treatment options expected to hinder the market growth.
The coronary heart disease medical devices market is projected to expand at a CAGR of 6.5% during the forecast period.
SynCardia Systems, Inc. (U.S.), Medtronic (U.S.), Berlin Heart GmbH (Germany), CHF Solutions, Inc. (U.S.), Teleflex Incorporated (U.S.)
North America is the fastest-growing region for the coronary heart disease medical devices market